Tokyo Tape
Sign in
← Nihon Trim

Half-year report · Q2

6788.TEDINET S100URRH
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥11.4bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥20.4bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥10.5bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥1.9bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥1.7bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥1.9bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥3.2bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.8bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥2.1bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥1.8bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥1.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.5bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥32.6bnat 2024-09-30Cons.Assets
Total assets¥31.5bnat 2024-03-31Cons.Assets
Total assets¥30.1bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥8.2bnat 2024-09-30Cons.Liabilities
Total liabilities¥7.9bnat 2024-03-31Cons.Liabilities
Net assets / equity¥24.4bnat 2024-09-30Cons.Net assets
Net assets / equity¥23.6bnat 2024-03-31Cons.Net assets
Net assets / equity¥22.5bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥15.7bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥14.0bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥15.7bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥14.0bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥13.3bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥12.8bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.0bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥1.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥883m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥149m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥703m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥998m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥985m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥170.42024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥280.512023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥155.762023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio70.3%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.7%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio71.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥1.4bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.4bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥215m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2024-04-01 → 2024-09-30¥9.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2024-04-01 → 2024-09-30¥9.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2024-04-01 → 2024-09-30¥1.6bn
—segment totalrevenue2024-04-01 → 2024-09-30¥11.4bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥11.4bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥1.9bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥194m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.5bn
—segment totalrevenue2023-04-01 → 2023-09-30¥10.5bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥10.5bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 506
ItemContextValueUnit
Noncurrent liabilitiesPrior1YearInstant1287211000JPY
Noncurrent liabilitiesCurrentQuarterInstant1412853000JPY
LiabilitiesPrior1YearInstant7917414000JPY
LiabilitiesCurrentQuarterInstant8224157000JPY
Capital stockPrior1YearInstant992597000JPY
Capital stockCurrentQuarterInstant992597000JPY
Capital surplusPrior1YearInstant1823945000JPY
Capital surplusCurrentQuarterInstant1823945000JPY
Retained earningsPrior1YearInstant22838855000JPY
Retained earningsCurrentQuarterInstant23456657000JPY
Treasury stockPrior1YearInstant-3448320000JPY
Treasury stockCurrentQuarterInstant-3448670000JPY
Shareholders equityPrior1YearInstant22207077000JPY
Shareholders equityCurrentQuarterInstant22824530000JPY
Valuation difference on available for sale securitiesPrior1YearInstant64947000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-10323000JPY
Foreign currency translation adjustmentPrior1YearInstant49075000JPY
Foreign currency translation adjustmentCurrentQuarterInstant127734000JPY
Remeasurements of defined benefit plansPrior1YearInstant-6603000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-5281000JPY
Valuation and translation adjustmentsPrior1YearInstant107420000JPY
Valuation and translation adjustmentsCurrentQuarterInstant112128000JPY
Non controlling interestsPrior1YearInstant1312848000JPY
Non controlling interestsCurrentQuarterInstant1472645000JPY
Net assetsPrior1YearInstant23627347000JPY
Net assetsCurrentQuarterInstant24409304000JPY
Liabilities and net assetsPrior1YearInstant31544761000JPY
Liabilities and net assetsCurrentQuarterInstant32633462000JPY
Net salesPrior1YTDDuration10452775000JPY
Net salesCurrentYTDDuration11361310000JPY
Cost of salesPrior1YTDDuration3082010000JPY
Cost of salesCurrentYTDDuration3383217000JPY
Gross profitPrior1YTDDuration7370764000JPY
Gross profitCurrentYTDDuration7978092000JPY
Selling general and administrative expensesPrior1YTDDuration5684573000JPY
Selling general and administrative expensesCurrentYTDDuration6121576000JPY
Operating incomePrior1YTDDuration1686191000JPY
Operating incomeCurrentYTDDuration1856516000JPY
Interest and dividends income noiPrior1YTDDuration13591000JPY
Interest and dividends income noiCurrentYTDDuration25932000JPY
Equity in earnings of affiliates noiPrior1YTDDuration8514000JPY
Equity in earnings of affiliates noiCurrentYTDDuration12303000JPY
Real estate rent noiPrior1YTDDuration41337000JPY
Real estate rent noiCurrentYTDDuration42008000JPY
Foreign exchange gains noiPrior1YTDDuration2865000JPY
Foreign exchange gains noiCurrentYTDDuration－JPY
Insurance premiums refunded cancellation noiPrior1YTDDuration5305000JPY
Insurance premiums refunded cancellation noiCurrentYTDDuration725000JPY
Gain on sales of noncurrent assets noiPrior1YTDDuration15577000JPY
Gain on sales of noncurrent assets noiCurrentYTDDuration18043000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass